Claudia Henschke, PhD, MD
August 2, 2022 —Ochsner Healthhas announced that the recipient of the37th Annual Alton Ochsner Award Relating Smoking and DiseaseisClaudia Henschke, Ph.D., M.D.Director, Early Lung and Cardiac Action Program (ELCAP) and Professor of Radiology at theIcahn School of Medicineat Mount Sinai, New York, N.Y.
This prestigious award is named afterAlton Ochsner, MD, who co-foundedOchsner Health in New Orleans并于1939年发表了第一篇将吸烟与健康联系起来的论文。它承认那些对吸烟与疾病之间的关系作出重大贡献的科学家，以及那些推动了重大预防和治疗方式的发展的科学家。
“It is an honor to receive this award for my work in lung cancer screening,” said Henschke. “The ability to be able to detect early lung cancer by screening and change it from an essentially incurable disease to one with a high cure rate, saving countless lives, is a culmination of 30 years of work.”
Henschke pioneered the use ofCT screeningforlung cancer, the leading cause of cancer death worldwide.
“I have had the rewarding experience of first introducing low-dose CT screening in 1992 when almost nobody really believed it would work, and then partnering with a global community of researchers known as the Early Lung Cancer Action Program (I-ELCAP). This has allowed screening to achieve mainstream acceptance,” she said.
“At Ochsner, we support pioneers who explore complex healthcare issues and develop innovative treatments relating to smoking cessation and disease prevention, because we know collaboration is a critical component of research and disease prevention,” saidLeonardo Seoane, MD, Chief Academic Officer for Ochsner Health. “We commend Dr. Henschke’s dedication and passion to this important topic.”
Starting in 2001, Henschke’s I-ELCAP research consortium expanded to 80 national and international sites focused on developing the most effective diagnostic protocol. It was constantly updated to incorporate imaging advances and improve diagnosis of lung cancer at ever earlier and more curable stages.
Her research triggered randomized controlled trials in the United States and five other countries that have validated mortality reductions, leading to public and private insurance coverage here and abroad. Her advancements have saved countless lives.
“I am most grateful for the participants in the screening program as they made all these results possible. This worldwide team effort is my greatest joy and I am honored to have had such a dedicated team of collaborators and participants,” Henschke said.
Henschke和她的团队利用有史以来最大的胸部CT扫描集之一，继续开发其他与吸烟相关的疾病的早期识别，如冠状动脉疾病、肺气肿、骨质疏松和肝脏疾病。
For more information:https://www.ochsner.org/
August 04, 2022
